These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6179667)

  • 1. Immunogenetic analysis of the HLA-D region: serological and cellular detection of the MB system.
    Duquesnoy RJ; Zeevi A; Marrari M; Halim K
    Clin Immunol Immunopathol; 1982 May; 23(2):254-68. PubMed ID: 6179667
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on human Ia supertypic specificities by complement fixation on PHA blasts. I. Serological properties of DC1 specificity.
    Guilherme L; Colombani M; Sansonetti N; Degos L; Colombani J
    Rev Fr Transfus Immunohematol; 1983 Sep; 26(4):379-94. PubMed ID: 6197740
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA and protein studies of HLA class II molecules: their relationship to T cell recognition.
    Segall M; Cairns JS; Dahl CA; Curtsinger JM; Freeman S; Nelson PJ; Cohen O; Wu S; Nicklas JN; Noreen HJ
    Immunol Rev; 1985 Jul; 85():129-48. PubMed ID: 3899914
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region.
    Nadler LM; Stashenko P; Hardy R; Tomaselli KJ; Yunis EJ; Schlossman SF; Pesando JM
    Nature; 1981 Apr; 290(5807):591-3. PubMed ID: 6163992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-reactive mouse anti-I-Ek monoclonal antibody detects an HLA-DR polymorphism linked to HLA-DR1.
    Birnbaum D; Dosseto M; Bourgue F; Pierres M; Kourilsky FM
    Mol Immunol; 1982 Jun; 19(6):755-64. PubMed ID: 6981060
    [No Abstract]   [Full Text] [Related]  

  • 6. Typing for human alloantigens with the primed lymphocyte typing technique.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Adv Immunol; 1982; 32():65-156. PubMed ID: 6180612
    [No Abstract]   [Full Text] [Related]  

  • 7. Serological distinction between DR antigens and lymphocyte activating determinants.
    van Heyningen V; Cohen BB; Deane DL; Gray C; Steel CM
    Tissue Antigens; 1981 Feb; 17(2):149-61. PubMed ID: 6165093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
    J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenetic aspects of the relationship between HLA-DR and the MB and MT system.
    Duquesnoy RJ
    Transplant Proc; 1981 Dec; 13(4):1804-7. PubMed ID: 6977217
    [No Abstract]   [Full Text] [Related]  

  • 10. Chimpanzee antibodies to purified human Ia-like B cell antigens.
    Ward FE; Johnson AH; Metzgar RS; Strong DM; Cresswell P
    Transplantation; 1981 Jul; 32(1):45-7. PubMed ID: 6973850
    [No Abstract]   [Full Text] [Related]  

  • 11. Alloantibodies that react with subsets of human T cells.
    van Leeuwen A
    Tissue Antigens; 1979 Nov; 14(5):437-43. PubMed ID: 12731575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological cross-reactivity of murine A.TH anti-A.TL antibody (anti-l-Ek antibody) with La-like molecules of human antigen-presenting cells.
    Okubo Y; Kusama S; Yamashita Y; Kitazawa K; Nagasaka M; Yano A
    Cell Immunol; 1983 Feb; 76(1):1-9. PubMed ID: 6187482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of anti-DQ alloantisera correlated with DR5.
    Crepaldi T; Fasano ME; Frattasio C; Centis D; Curtoni ES; Richiardi P
    J Immunogenet; 1985 Dec; 12(6):301-8. PubMed ID: 2426368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
    Feighery CF; Stastny P
    Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B cell alloantigens: expression of MB and MT determinants.
    Markert ML; Cresswell P
    J Immunol; 1982 May; 128(5):2004-8. PubMed ID: 6174619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HLA-D/DR-locus: its structure, function and role in infectious diseases].
    Pospelov LE
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):14-20. PubMed ID: 6084376
    [No Abstract]   [Full Text] [Related]  

  • 18. [The human major histocompatibility complex or HLA complex].
    Lemonnier FA
    Biochimie; 1985 Jan; 67(1):XI-XV. PubMed ID: 2581625
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones.
    Jacobson S; Nepom GT; Richert JR; Biddison WE; McFarland HF
    J Exp Med; 1985 Jan; 161(1):263-8. PubMed ID: 2578544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to human Ia-like antigens and heterologous anti-human lymphocyte sera.
    Wilson BS; Ferrone S
    J Immunogenet; 1981 Feb; 8(1):1-5. PubMed ID: 6972978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.